Tuberculosis surveillance: Data for decision-making

Clinical Infectious Diseases

Volumn 44, Issue 10, 2007, Pages 1267-1270

  Castro, Kenneth G ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE SURVEILLANCE; EUROPEAN UNION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL DECISION MAKING; NOTE; PRIORITY JOURNAL; TUBERCULOSIS; DECISION MAKING; EUROPE; HEALTH SURVEY; HUMAN IMMUNODEFICIENCY VIRUS; METHODOLOGY; MICROBIOLOGY; MYCOBACTERIUM TUBERCULOSIS; VIROLOGY;

DECISION MAKING; EUROPE; EUROPEAN UNION; HIV; HIV INFECTIONS; HUMANS; MYCOBACTERIUM TUBERCULOSIS; POPULATION SURVEILLANCE; TUBERCULOSIS;

EID: 34248143505     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/514351     Document Type: Note

References (17)

1. Frost WH. The age selection of mortality from tuberculosis in successive decades. Am J Hyg 1939; 30:91-6.
2. Falzon d, Ait-Belgini F. What is tuberculosis surveillance in the European Union telling us? Clin Infect Dis 2007; 44:1261-7 (in this issue).
3. Rieder HL, Watson J, Raviglione M, et al. Surveillance of tuberculosis in Europe. Recommendations of a working group of the World Health Organization (WHO) and the European Region of the International Union Against Tuberculosis and Lung Diseases (IUATLD) for uniform reporting on tuberculosis cases. Eur Respir J 1996; 9:1097-104.
4. World Health Organization. Interim policy on collaborative TB/HIV activities. Document no. WHO/HTM/TB/2004.330. Geneva: World Health Organization, 2004.
5. Hopewell PC, Pai M, Maher D, Uplekar M, Raviglione MC. International standards for tuberculosis care. Lancet Infect Dis 2006; 6:710-25.
6. Broekmans JF, Migliori GB, Rieder HL, et al. European framework for tuberculosis control and elimination in countries with a low incidence. Recommendations of the World Health Organization (WHO), International Union against Tuberculosis and Lung Diseases (IUATLD), and the Royal Netherlands Tuberculosis Association (KNCV) Working Group. Eur Respir J 2002; 19:765-75.
7. Leimane V, Leimans J. Tuberculosis control in Latvia: integrated DOTS and DOTS-plus programmes. Euro Surveill 2006; 11:29-33.
8. Leimane V, Riekstina V, Holtz TH, et al. Clinical outcome of individualized treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study. Lancet 2005; 365:318-26.
9. Centers for Disease Control and Prevention. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs - worldwide, 2000-2004. MMWR Morb Mortal Wkly Rep 2006; 55:301-5.
10. Gandhi NR, Moll A, Sturm AW, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006; 368:1575-80.
11. Centers for Disease Control and Prevention. Revised definition of extensively drug-resistant tuberculosis. MMWR Morb Mortal Wkly Rep 2006; 55:1176. Available at: http://www.cdc.gov/mmwr/PDF/wk/mm5543.pdf. Accessed 3 March 2007.
12. World Health Organization (WHO). Report of the meeting of the WHO global task force on XDR-TB. Geneva: WHO, 2007. Available at: http://whqlibdoc.who.int/ hq/2007/WHO_HTM_TB_2007.375_eng.pdf. Accessed 24 March 2007.
13. Dye C. Global epidemiology of tuberculosis. Lancet 2006; 367:938-40.
14. World Health Organization. The global plan to stop TB, 2006-2015. Document no. WHO/HTM/TB/2006.35. Geneva: World Health Organization, 2006.
15. McKenna MT, McCray E, Onorato I. The epidemiology of tuberculosis among foreign-born persons in the United States, 1986 to 1993. N Engl J Med 1995; 332:1071-6.
16. Zuber PL, McKenna MT, Binkin NJ, Onorato IM, Castro KG. Long-term risk of tuberculosis among foreign-born persons in the United States. JAMA 1997; 278:304-7.
17. Schwartzman K, Oxlade O, Graham Barr R, et al. Domestic returns from investment in the control of tuberculosis in other countries. N Engl J Med 2005; 353:1008-20.